Toulon Cedex

France

15 total trials 4 recruiting

Filter these 15 trials by phase, condition, sponsor and more.

Open in Search →

METAREM / META-1 - METAREM :Immunotherapy Master Trial for Advanced Cancers / META-1: Immunotherapy without chemotherapy for advanced lung c … Pending

2025-522655-26-00 4 METAREM:Patients with advanced cancer, as defined as unresectable loca
ADRESS : Efficacy of the Alpha 2 agonist dexmedetomidine for sympathetic Deactivation in REfractory Septic Shock: a randomized, controlled t … Pending

2025-524122-18-00 5 Septic shock
Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma Recruiting

2024-519208-29-00 4 2026-04-02 Pleural mesothelioma
Single Arm Study of WSD0922-FU for NSCLC Patients with C797S mutation Recruiting

2024-519713-65-00 4 2025-09-04 Non-Small Cell Lung Cancer
Evaluating ivonescimab as a potential treatment for pleural mesothelioma patients whose cancer has returned after previous immunotherapy and … Recruiting

2024-519052-82-00 4 2025-06-30 pleural mesothelioma
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients with Operable No … Recruiting

2023-509806-31-00 4 2025-02-11 Non-Small Cell Lung Cancer
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer Ended recruitment

2024-512998-27-00 5 2025-02-21 Non-Small Cell Lung Cancer
Management of moderate POstoperative recurrence in Crohn's disease: a randoMizEd contROLled trial of therapeutic escalation, the POMEROL tri … Ended recruitment

2023-508242-18-00 6 2021-12-21 Crohn's disease
Randomized trial of avelumab-cetuximab-Radiotherapy versus standards of care in the head and neck cancers Ended recruitment

2024-513964-24-00 5 2017-09-14 Squamous cell carcinoma, previously untreated Stage III, stage IVa (op
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lun … Ended recruitment

2023-505981-26-00 5 2015-11-20 Non−Small Cell Lung Cancer
Chemotherapy or chemotherapy + hormonotherapy in women over 70 with HER2 receptor-negative but estrogen receptor-positive breast cancer acco … Ended recruitment

2024-516996-34-00 5 2012-04-12 oestrogen-receptor (ER)-positive HER2-negative breast carcinoma
Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients Ended recruitment

2024-515171-35-00 5 2011-07-06 Prostatic adenocarnicoma with high risk of recurrence
Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants wit … Ended

2023-508443-40-00 5 2020-12-18 Lung Cancer, Non-Small Cell
A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Ri … Ended

2023-504036-17-00 5 2020-05-07 Chronic Lymphocytic Leukemia (CLL)
A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 in Completely Resected Non-Small Cell Lung Can … Ended

2024-517856-36-00 5 2015-03-09 Completely resected primary stage IB (≥ 4cm), II and IIIA non-small ce

Showing 1–15 of 15 trials